Table of Content


1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Infectious Diseases
4.2.2 Rising Geriatric Population
4.2.3 Increasing Awareness of the Advantages of the Vial Adaptors
4.3 Market Restraints
4.3.1 Availability of Substitutes
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Material
5.1.1 Polycarbonate
5.1.2 Silicon
5.1.3 Polyethylene
5.1.4 Others
5.2 By Therapeutic Area
5.2.1 Autoimmune Diseases
5.2.2 Infectious Diseases
5.2.3 Metabolic Conditions
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Miltenyi Biotec
6.1.2 Baxter International Inc.
6.1.3 Randox Laboratories Ltd
6.1.4 Sartorious AG
6.1.5 West Pharmaceutical Services, Inc.
6.1.6 Thermo Fisher Scientific
6.1.7 Agilent Technologies
6.1.8 Becton, Dickinson and Company
6.1.9 B. Braun Medical Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS